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ABSTRACT
Rabbits were vaccinated once, by subcutaneous and intradermal injection, with sonicates of onco-
spheres (TpO) or conditioned media from in vitro maintained mature metacestodes (TpMcES) of
Taenia pisiformis. Extracts were either incorporated into or mixed with unilammelar liposomes (reverse
phase evaporative vesicles) or emulsified in Freund's Incomplete Adjuvant (FIA). Control groups
received liposomes or FIA without antigen, or antigen preparation without adjuvant. Rabbits were
challenged orally two weeks after vaccination with approximately 1500 eggs of T. pisiformis and necro-
psied eight weeks after challenge. A mean of 155 cysts was recovered from seven control rabbits.
A 67% reduction in peritoneal cyst numbers was obtained in TpO-IFA vaccinated rabbits compared to
75% for the TpO-liposome entrapped group. The highest level of protection (86%) was obtained when
TpO was mixed with but not entrapped in liposomes. Only 32% and 39% reduction in peritoneal cyst
numbers was obtained after immunizing with the TpMcES preparation in liposomes or IFA respectively,
however >85% of peritoneal metacestodes were dead (necrotic or calcified) and suggests a different
immune response than occurs after vaccination with oncosphere extracts. Specific anti-oncospheral or
anti-metacestode ES antibody (IgG) responses at two weeks post vaccination were similar in rabbits
immunized with liposome or IFA associated extracts.
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INTRODUCTION
The ability to immunize animals against taeniid larval cestode infection using living
oncospheres or their extracts (sonicates or in vitro culture 'ES' preparations) has
been convincingly demonstrated to varying degrees in mice, rabbits, sheep and
cattle (see reviews, FLISSER et ah, 1979; RICKARD, 1982; RICKARD & WILLIAMS,
1982). However, in almost all cases where oncospheral antigen preparations were
used as experimental vaccines, they were associated with an adjuvant, notably
Freund's Complete (FCA) or Incomplete (FIA) adjuvants. Unfortunately Freund's
adjuvant is only acceptable for use in experimental animals and is definitely not
acceptable for human use due largely to problems of granuloma formation, plasma
cell tumours (in mice) and mineral oil persistence (refs cited by SIDDIQUI et ai,
1981).
There is therefore a need to investigate alternative ways of presenting
immunizing antigens to the host, especially if practical vaccination against human
cysticercosis {Taenia solium) or human hydatidosis (Echinococcus granulosus and
E. multilocularis) ever becomes a feasible proposition. The use of liposomes could
provide a useful and acceptable alternative to mineral oil based adjuvants.
Liposomes, originally described by BANGHAM et al. (1965) are microvesicles
artificially composed of phospholipid membranes enclosing an aqueous compart-
ment, which have remarkable similarities to biological membranes and exhibit
immune adjuvant properties (TOM, 1980). Liposomes are readily taken up by
macrophages and thus the liver is an important target organ. Most applications to
date of liposomes in parasitology have involved targetting chemotherapy of
protozoal infections (CROFT, 1986).
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Here we report the use of liposomes to immunize rabbits against oral infection
with T. pisiformis, a natural taeniid of rabbits. The results were compared with the
use of Freund's Incomplete Adjuvant.
MATERIALS AND METHODS
Rabbits and vaccination protocol
Thirty-two, 16 week old female NZ white rabbits were divided into vaccination
and control groups (see Table I). Rabbits were vaccinated intradermally and
subcutaneously 0-5 ml total volume (approximately 300 ug protein) on Day 0,
challenged orally two weeks later with approximately 1500 eggs per rabbit of T.
pisiformis and necropsied eight weeks after challenge. The numbers of cysts in the
peritoneal cavity (including liver surface) were counted and their viability noted
macroscopically. Control groups were injected with FIA or liposomes without
antigen or with immunizing antigen alone. Rabbits were ear bled at various
intervals and sera stored at —30°C until used.
Immunizing extracts of T. pisiformis
Oncospheres were artificially hatched from eggs of T. pisiformis and purified on
Percoll (Pharmacia) to remove shell components and unhatched eggs (RAJASEKAR-
IAH et ai, 1980), and sonicated in 0-15 M phosphate buffered saline pH 7-2 (PBS)
as described by CRAIG & RICKARD (1981). The oncospheral sonicate was
centrifuged at 500 g for 30 mins at 4°C and the supernatant used as the immunogen
(TpO). Each rabbit was vaccinated with the product of approximately 75 000
oncospheres.
An excretory-secretory (ES) antigen extract was prepared from the mature
metacestode stage maintained in vitro, essentially as described elsewhere (CRAIG,
1984). Briefly, 'conditioned' serum-free media (DMEM + 20 mM hepes + 1%
glucose) was harvested every third day from 20 mestacestodes in a 10*ml culture,
pooled and concentrated through a 10 000 Mwt filter (Amicon Corp) and
designated TpMcES.
Liposomes
Unilammelar reverse phase evaporative vesicles (REVs) were prepared
essentially as described by SZOKA & PAPHADJOPOULOS (1978). 20 mg sphingo-
TABLE I. Mean numbers of cysts of Taenia pisiformis present in peritoneal cavity of vaccinated or
control rabbits
Vaccination group
Control (lip)
(IFA)
TpO alone
TpO+lip
TpO+IFA
TpO+lip ("free")
TpMcES alone
TpMcES±lip
TpMcES ± IFA
No. rabbits
7
4
4
4
4
3
3
3
No.
Range
64-310
49-80
22-80
34-73
12-43
74, 95, 165
60, 105, 150
53, 88, 140
cysts
Mean±S.D.
155±90
62±14
39±18a
52±19
22±14b
111+48
105±45
94±44
% cysts necrotic
mean
8
30
50
80
10
85
95
100
% protection
60
75
67
86
28
32
39
Students t-test: b vs a—p<005. lip=liposomes. IFA=Incomplete Freund's Adjuvant. TpO = T. pisiformis
oncosphere extract. TpMcES=T. pisiformis metacestode "ES" extract.
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myelin (Sigma) and 8 mg cholesterol (recrystallized) were dissolved in 3 ml
chloroform in a stoppered glass test tube suspended in a 37°C water bath. To this
was added 3 ml of ether and then 1 ml of antigen and the mixture bath sonicated (at
37°C). Solvent was removed by rotary evaporation at 37°C for 30 mins. After
vortex mixing REVs (liposomes) were produced.
In addition, liposomes were prepared exactly as above but without antigen
('empty') and used as controls. Also a batch of 'empty' liposomes were incubated in
antigen solution at room temperature for 1 hr (i.e. antigen not entrapped in
liposomes).
Freund's Adjuvant
The TpO and TpMcES antigen preparations were emulsified in equal volumes
of Freund's Incomplete Adjuvant (Sigma)
Enzyme linked immunosorbent assay (ELISA)
The method of ELISA for detecting specific IgG antibodies to the TpMcES and
TpO antigen preparations was essentially as described previously (CRAIG &
RICKARD, 1981; CRAIG, 1984). Antigens were used to coat plates at ~ 5 ug prot/ml
and all incubations carried out at 4°C. Rabbit sera were used at a dilution of 1:150.
RESULTS
The mean numbers of cystic metacestodes obtained from the peritoneal cavity
of rabbits in vaccinated and control groups is shown in Table I. A mean of 155 cysts
per rabbit (range 64-310) were counted in the control group (FIA or liposomes
without antigen) and approximately 92% appeared viable. Vaccination of rabbits
with oncospheral sonicate TpO entrapped inside liposomes resulted in a 75%
reduction in cyst numbers. This was comparable to the 67% reduction in cyst
numbers obtained when TpO-FIA was used to immunize rabbits. However the
greatest degree of protection, 86% was obtained in the group vaccinated with
liposomes which had only been passively incubated in the TpO preparation, i.e. the
antigen was not entrapped within the liposomes. Vaccination with TpO alone
resulted in 60% protection.
In contrast, the level of protection obtained when rabbits were vaccinated with
the TpMcES preparation, either in liposomes or FIA or alone was much lower, i.e.
32%, 39% and 28% respectively. However, a greater proportion of the cysts
(85-100%) observed in the TpMcES vaccinated rabbits were dead, necrotic and/or
partially calcifying, compared to the TpO vaccinated groups (Table I).
Measurement of specific IgG antibody responses using TpO or TpMcES antigen
preparations in the ELISA revealed very similar responses in rabbits for both
liposome or FIA associated vaccine groups (Fig. 1). There was perhaps some
indication that anti-TpO antibody responses were maintained for a longer duration
in the TpO-FIA group compared to the TpO-liposome group.
DISCUSSION
A significant degree of protection (75% and 86%) against oral challenge with T.
pisiformis eggs was obtained in rabbits immunized with a crude low speed sonicate
of T. pisiformis oncospheres entrapped in, or passively coated onto liposomes
(REVs). This level of protection was at least as good as that obtained when the
oncospheral sonicate (TpO) was injected after being emulsified in Freund's
Incomplete Adjuvant (i.e. 67%). RAJASEKARIAH et al. (1985) used similar TpO
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FIG. 1. Serum antibody responses (IgG-ELISA) against a) TpO or b) TpMcES extracts in groups of
rabbits vaccinated by a) oncospheral or b) metacestode (McES) extracts in liposomes or FIA, or PBS
'controls' in liposomes. wpv=weeks post vaccination; wpc=weeks post challenge.
sonicates to vaccinate rabbits, and obtained 90% protection, after two intramuscular
injections two weeks apart in Freund's Complete Adjuvant followed by FIA
respectively. In the present study the greatest level of protection (86%) was
achieved after a "single" injection with TpO coated onto the surface of liposomes.
This level of protection was greater than the 60% level obtained after vaccination
of rabbits with TpO alone or the 76% level obtained when the TpO preparation
was entrapped inside liposomes. This suggests that functional antigen in TpO may
be better presented to the immune effector cells, e.g. macrophage on the liposome
surface. Interestingly VAN ROOIJEN & VAN NIEUWMEGEN (1980) observed a similar
result when they measured the immune response in rabbits against human serum
albumin (HSA) that had been coated on 'empty' liposomes or entrapped in the
vesicles. The greatest responses were associated with liposome surface coated
HSA, and these authors suggested that adjuvant effects of liposomes are mediated
by antigen exposed on the liposome surface.
In contrast to the immunity obtained by TpO vaccination against invading
oncospheres from the oral egg challenge, which is probably effective in rabbits 3—5
days after infection (RAJASEKARIAH et al., 1985), it appears from the present study
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that a different immune response is active in the TpMcES vaccinated rabbits and is
directed at the later metacestode stages. This was manifested by the presence of
large numbers of dead or necrotic larvae in the peritoneal cavity. These
observations fit in with the concept of post-encystment immunity, where the
immune response affects the mature or established parasite rather than the early
oncosphere stage (see reviews by GEMMELL & SOULSBY, 1968; RICKARD &
WILLIAMS, 1982). However from our own experiments we cannot say at what time
after infection metacestodes become susceptible to the immune response, but it is
likely to be after emergence from the liver (i.e. 2-3 weeks post infection).
In summary, liposome entrapped low speed supernatants of TpO sonicates gave
as good protection against the development of rabbit cysticercosis as TpO
emulsified in FIA. Functional oncospheral antigen(s) in T. pisiformis may be more
effectively presented to the host immune system on the liposomes surface.
Vaccination with the TpMcES from the mature metacestode (in liposomes or FIA)
did not prevent infection, but appeared to be effective in destroying the more
mature metacestodes.
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